Healthcare DIVE March 4, 2021
Nick Paul Taylor

Dive Brief:

  • FDA has shared a Data Modernization Action Plan setting out its response to the proliferation and diversification of data sources. Through DMAP, FDA aims to identify and run data projects with measurable value, develop repeatable practices and build a talent network.
  • FDA is working toward those goals in the belief that “even small advances in our ability to gain useful insights from data can represent significant opportunities,” Janet Woodcock and Amy Abernethy, respectively the acting commissioner and acting chief information officer at FDA wrote in a blog post.
  • In 2019, FDA created the Technology Modernization Action Plan. The plan set out the near-term actions the agency proposed to take to equip itself to “securely receive, store, exchange,...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Big Data, Digital Health, FDA, Govt Agencies, Technology
Roche Drug Scores Label Expansion for Earlier Use in Lung Cancer
Opinion: STAT+: How AI can help satisfy FDA’s drug, device diversity requirements
FDA wants to boost trial innovation with new center at CDER
Stelara biosimilar from Alvotech, Teva approved by FDA
Scopio Labs Receives FDA Clearance For AI-Driven Bone Marrow Analysis Application

Share This Article